ATAI
primary week value value statistically significant treatment difference at visit day day week week week week week comparator phase trial showed a rapid sustained reduction in depressive | ATAI
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
20 of 41
Related slides by other companies
argenx SE
Investor Presentation
November 2023
advance trial topline data expected | argenx SE
Kymera
Investor Presentation
June 2023
case study patient | Kymera
Oculis
Investor Conference
June 2023
phase program in patients | Oculis
Oculis
Results
May 2023
next step phase trial stage | Oculis
Other recent decks by ATAI
See all presentations (13 decks)
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io